| 1 |
Physiological and pathophysiological mechanisms of the molecular and cellular biology of angiogenesis and inflammation in moyamoya angiopathy and related vascular diseases |
|
| | Kirsten B. Dorschel, John E. Wanebo | | | Frontiers in Neurology. 2023; 14 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Identification of immune-infiltrated hub genes as potential biomarkers of Moyamoya disease by bioinformatics analysis |
|
| | Fa Jin, Chuanzhi Duan | | | Orphanet Journal of Rare Diseases. 2022; 17(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
RNF213 gene silencing upregulates transforming growth factor ß1 expression in bone marrow-derived mesenchymal stem cells and is involved in the onset of Moyamoya disease |
|
| | Changshui Wang,Cuilian Sun,Yueshu Zhao,Huimin Song,Zhengyou Li,Feng Jin,Changmeng Cui | | | Experimental and Therapeutic Medicine. 2021; 22(3) | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Overexpression of circRNA circUCK2 Attenuates Cell Apoptosis in Cerebral Ischemia-Reperfusion Injury via miR-125b-5p/GDF11 Signaling |
|
| | Wanghao Chen,Hong Wang,Jia Feng,Lukui Chen | | | Molecular Therapy - Nucleic Acids. 2020; 22: 673 | | | [Pubmed] [Google Scholar] [DOI] | |
|
